Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody... ( Two Separate Clinical Studies Planne...)

HOME >> MEDICINE >> TECHNOLOGY

Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342

Date:12/4/2007

Two Separate Clinical Studies Planned for Cancer and Inflammatory Disease

PRINCETON, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today the allowance of two separate investigational new drug applications (IND) filed with the U.S. Food & Drug Administration (FDA) for MDX-1342, one for the treatment of chronic lymphocytic leukemia (CLL) and the other for rheumatoid arthritis. MDX-1342 is a fully human antibody that targets CD19, a molecule specifically expressed on normal B-cells and malignant B-cells in diseases such as CLL, acute lymphoblastic leukemia, follicular non-Hodgkins lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma.

The IND for the treatment of CLL is for an open-label, multi-dose, dose-escalation Phase I clinical trial for cancer that is expected to enroll up to 52 patients with relapsed or refractory CLL. This trial is designed to establish and evaluate the safety, tolerability and maximum tolerated dose, as well as preliminary pharmacodynamics and efficacy of MDX-1342.

The IND for the treatment of rheumatoid arthritis is for a randomized, single-dose, dose-escalation, placebo-controlled Phase I clinical trial that is expected to enroll up to 90 patients with rheumatoid arthritis. This trial is designed to evaluate the safety and tolerability profile of MDX-1342 and to determine the dose range for B-cell depletion.

"We are pleased with the advancement of a new product candidate from Medarex's proprietary pipeline into clinical trials," said Howard H. Pien, President and CEO of Medarex. "We look forward to the continued development of MDX-1342, which could provide new treatment options for a number of serious conditions."

About
'/>"/>

SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:

(Date:5/20/2013)... Quebec , May 20, 2013 Valeant Pharmaceuticals International, ... members of its senior management team will make a presentation ... on Tuesday, June 11, 2013 at 9:20 a.m. PT. The ... Los Angeles, CA. A live ... on the company,s Web site at www.valeant.com . Click ...

(Date:5/20/2013)... BATESVILLE, Ind. , May 20, 2013 Hill-Rom ... to listen to a management presentation at the 38 ... Boston on May 30, 2013, ... ) You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ...

(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...

Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2 Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3

[0] Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference [0] Hill-Rom to Participate in the 38th Annual Deutsche Bank Health Care Conference [0] Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt

... Ontario, July 18, 2011 CardioGenics Holdings Inc. (CGNH.OB) ... available for on-demand viewing at the RetailInvestorConferences website. ... will be available 24/7 for 90 days. Investors may ... the next three weeks. About CardioGenics ...

... July 18, 2011 Coronado Biosciences, Inc. (the "Company"), ... immunotherapy agents for the treatment of autoimmune diseases and ... on Form 10 with the Securities and Exchange Commission ... the purpose of becoming a reporting company. The filing ...

Cached Medicine Technology:CardioGenics Holdings Inc. Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2 Coronado Biosciences Files to Become a Public Reporting Company 2

CardioGenics Holdings Inc. Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com Coronado Biosciences Files to Become a Public Reporting Company

(Date:5/21/2013)... According to the Center for Disease Control and Prevention (CDC), ... Over 800,000 of these bites require medical attention, half of ... aware of the danger that dog bites pose to their ... may sustain more serious injuries than an adult. For ... of 5 and 9 are at the greatest risk of ...

(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...

(Date:5/20/2013)... This week has been dedicated as National Dog Bite Prevention ... an awareness campaign designated to help prevent dog bite injuries ... properly train their pets, and educate children on how to ... at Buckfire & Buckfire, P.C. represent victims of dog bites ... law firm is a large advocate of this week as ...

(Date:5/20/2013)... Minneapolis, MN (PRWEB) May 20, 2013 When ... right bed is only part of the process. Much of ... over the internet involves not knowing what to expect. ... expert advice consumers can use to ensure their purchase proves ... When You Buy a Mattress Online ”, readers find helpful ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 The new ... lives and health of all Americans. However, not all ... immediate impact as some might take up to 2014 ... Human Services (HHS), some states are currently moving forward ... Insurance Marketplaces, such as: Iowa, Michigan, New Hampshire, and ...

Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2 Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2 Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3 Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2 Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2 Health News:Review of Health Bill Impact in 2014 2 Health News:Review of Health Bill Impact in 2014 3

[0] Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries [0] Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards [0] Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week [0] See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online [0] Review of Health Bill Impact in 2014

... ... launches SafeConsole 4.0, the web management software for SafeStick, the secure USB flash drive. ... administrators through a series of new features and range of licensing options. , ... Washington, DC (PRWEB) December ...

... , , ... a new market research report is available in ... Industry in the U.S. and its International Trade ... , The newly published In-Vitro Diagnostic Substance Manufacturing ...

... , , , ... a new market research report is available in ... Autoimmune Diseases Therapeutics - Market Forecasts to 2015, ... , http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html , Summary ...

... , SANTA CLARA, Calif., Dec. 15 ... into Santa Clara County for the first time since ... Administrators will be assuming responsibilities and provider contracts previously ... , Operating on a locally based healthcare philosophy, Coastal ...

... is widely thought to be the major form of the ... Research Program (MHRP) researchers, however, have demonstrated that essentially all ... of red blood cells isolated from each of 30 normal ... PLoS ONE , and can be accessed here. ...

... 2009Do good-looking people really benefit from their looks, and in ... Georgia and the University of Kansas found that yes; attractive ... an increased sense of psychological well-being. This seems like common ... each year trying to become more attractive. However, the study, ...

BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Coastal Healthcare Administrators Expands Provider Network to Santa Clara County New insight into selective binding properties of infectious HIV The importance of attractiveness depends on where you live

FREEDOM® Memory Thumb Spica lets you make a custom splint in minutes. Immerese in 160 F water until pliable, and remove. Amazingly, it maintains its shape and is ready to be precisely, profession...

... QuickCast® Cast-like splints Slip ... dryer, and QuickCast conforms to ... cools. Reheat to adjust and ... coated with a temperature-sensitive polymer ...

... strong, the ThumSaver CMC Short lessens symptoms of ... and/or MP joints of the thumb. The ThumSaver ... IP joint motion for function. Includes felt padding ... and for rest due to repetitive stress injuries. ...

... an excellent choice to treat DeQuervain's Tendonitis, ... basal joint arthritis, advanced carpal tunnel syndrome ... and wrist. Distal palmar crease contour ... full finger dexterity. Constructed from an ...

Medicine Products:

FREEDOM® Memory Thumb Spica QuickCast® Sport Thumb Splint ThumSaver™ CMC Short 2087 LIGHTWEIGHT BREATHABLE WRIST/THUMB SPLINT